medigraphic.com
ISSN 2594-1526 (Electronic)
Antes Revista del Instituto Nacional de Enfermedades Respiratorias

 Ver anteriores al 2010

2016, Number 4

<< Back Next >>

Neumol Cir Torax 2016; 75 (4)

Procedure EXIT (ex utero intrapartum) for high risk congenital bronchopulmonary malformations. Description of the art and literature review

Sancho-Hernández R, Solorio-Rodríguez L, Durán-Colín AA, Cuevas-Schacht FJ

Language: Spanish
References: 30
Page: 281-290
PDF size: 963.82 Kb.


ABSTRACT

Introduction: Prenatal ultrasonographic now represents a form of presentation of congenital bronchopulmonary malformations (CBPM), these intrathoracic lesions can cause polyhydramnios, mediastinal shift, hydrops and fetal death, it presents the first national report and process engineering EXIT described (ex utero intrapartum) as an option for these fetal lung masses high risk. Description of cases: Fetus 30 SG with a microcystic mass of the entire left lung with mediastinal shift and fetal hydrops, with a CVR 2.7, the pregnancy was carried to term and procedure EXIT is carried out with the support of utero flow successful placental 63 minutes with selective intubation of right bronchus by rigid bronchoscopy and left pneumonectomy a solid lesion compatible with MAQ type I diffuse and isolated pockets of type 0, patient died from pulmonary complications associated with barotrauma and hypoplasia and hypertension refractory to management conventional. Discussion: The EXIT procedure in our area may represent a therapeutic option for high-risk MCBP persistent near-term birth mediastinal deviation; the diffuse involvement of the affected lung, contralateral pulmonary hypoplasia and pulmonary hypertension refractory remain the defining factors perinatal mortality.


REFERENCES

  1. Hedrick HL, Flake AW, Crombleholme TM, et al. The ex utero intrapartum therapy procedure for high-risk fetal lung lesions. J Pediatr Surg 2005;40(6):1038-1044.

  2. Cass DL, Olutoye OO, Cassady CI, et al. EXIT-to resection for fetuses with large lung masses and persistent mediastinal compression near birth. J Pediatr Surg 2013;48(1):138-144. doi: 10.1016/j.jpedsurg.2012.10.067.

  3. Miniati DM, Chintagumpala M, Langston C, et al. Prenatal presentation and outcome of children with pleuropulmonary blastoma. J Pediatr Surg 2006;41(1):66-71.

  4. Lazar DL, Cass DL, Dishop MK, et al. Fetal lung interstitial tumor: a cause of late gestation fetal hydrops. J Pediatr Surg 2011;46(6):1263-1266. doi: 10.1016/j.jpedsurg.2011.02.056.

  5. Cass DL, Olutoye OO, Cassady CI, et al. Prenatal diagnosis and outcome of fetal lung masses. J Pediatr Surg 2011;46(2):292-298. doi: 10.1016/j.jpedsurg.2010.11.004.

  6. Sancho HR, Solorio RL, Duran CA, et al. Secuestro pulmonar extralobar asintomático y la importancia del diagnóstico y tratamiento perinatal: el manejo expectante no es una opción terapéutica. Neumol Cir Torax 2015;74(4):262-270.

  7. Adzick NS. Management of fetal lung lesions. Clin Perinatol 2009;36(2):363-376, x. doi: 10.1016/j.clp.2009.03.001.

  8. Grethel EJ, Wagner AJ, Clifton MS, et al. Fetal intervention for mass lesions and hydrops improves outcome: a 15 year experience. J Pediatr Surg 2007;42 (1):117-123.

  9. Curran PF, Jelin EB, Rand L, et al. Prenatal steroids for microcystic congenital cystic adenomatoid malformations. J Pediatr Surg 2010;45(1):145-150. doi: 10.1016/j.jpedsurg.2009.10.025.

  10. Harrison MR, Adzick NS, Flake AW, et al. Correction of congenital diaphragmatic hernia in utero VIII: Response of the hypoplastic lung to tracheal occlusion. J Pediatr Surg 1996;31(10):1339-1348.

  11. Marwan A, Crombleholme TM. The EXIT procedure: principles, pitfalls, and progress. Semin Pediatr Surg 2006;15(2):107-115.

  12. Dighe MK, Peterson SE, Dubinsky TJ, Perkins J, Cheng E. EXIT procedure: technique and indications with prenatal imaging parameters for assessment of airway patency. Radiographics 2011;31(2):511-526. doi: 10.1148/rg.312105108.

  13. Thorper-Beeston JG, Nicolaides KH. Cystic adenomatoid malformation of the lung: prenatal diagnosis and outcome. Prenat Diagn 1994;14(8):677-688.

  14. Adzick NS. Management of fetal lung lesions. Clin Perinatol 2003;30(3):481-492.

  15. Adzick NS, Harrison MR, Glick PL, et al. Fetal cystic adenomatoid malformation: prenatal diagnosis and natural history. J Pediatr Surg 1985;20(5):483-488.

  16. Adzick NS. Open fetal surgery for life-threatening fetal anomalies. Semin Fetal Neonatal Med 2010;15(1):1-8. doi: 10.1016/j.siny.2009.05.003.

  17. Roggin KK, Breuer CK, Carr SR, et al. The unpredictable character of congenital cystic lung lesions. J Pediatr Surg 2000;35(5):801-805.

  18. Cass DL, Crombleholme TM, Howell LJ, Stafford PW, Ruchelli ED, Adzick NS. Cystic lung lesions with systemic arterial blood supply: a hybrid of congenital cystic adenomatoid malformation and bronchopulmonary sequestration. J Peditr Surg 1997;32(7):986-990.

  19. Stanton M, Njere I, Ade-Ajayi N. Patel S, Davenport M. Systematic review and meta analysis of the postnatal management of congenital cystic lung lesions. J Pediatr Surg 2009;44(5):1027-1033. doi: 10.1016/j.jpedsurg.2008.10.118.

  20. Durell J, Thakkar H, Gould S, Fowler D, Lakhoo K. Pathology of asymptomatic, prenatally diagnosed cystic lung malformations. J Pediatr Surg 2016;51(2):231-235. doi: 10.1016/j.jpedsurg.2015.10.061.

  21. Crombleholme TM, Coleman B, Hedrick H, et al. Cystic adenomatoid malformation volume ratio predicts outcome in prenatally diagnosed cystic adenomatoid malformation of the lung. J Pediatr Surg 2002;37(3):331-338.

  22. Ehrenberg-Buchner S, Stapf AM, Berman DR, et al. Fetal lung lesions: can we start to breathe easier? Am J Obstet Gynecol 2013;208(2):151.e1-7. doi: 10.1016/j.ajog.2012.11.012.

  23. Liechty KW. Ex utero intrapartum therapy. Semin Fetal Neonatal Med 2010;15(1):34-39. doi: 10.1016/j.siny.2009.05.007.

  24. Marwan A, Crombleholme TM. The EXIT procedure: principles, pitfalls, and progress. Semin Pediatr Surg 2006;15(2):107-115.

  25. Sancho HR, Solorio RL, Durán CA, Cuevas SFJ, López CE. Tratamiento perinatal de las malformaciones congénitas broncopulmonares en un país en vías de desarrollo: el punto de vista de la cirugía de tórax pediátrica [resumen]. Neumol Cir Torax 2015;74(1):72.

  26. Moldenhauer JS. Ex utero intrapartum therapy. Semin Pediatr Surg 2013;22(1):44-49. doi: 10.1053/j.sempedsurg.2012.10.008.

  27. Stoffan AP, Wilson JM, Jennings RW, Wilkins-Haug LE, Buchmiller TL. Does the ex utero intrapartum treatment to extracorporeal membrane oxygenation procedure change outcomes for high-risk patients with congenital diaphragmatic hernia? J Pediatr Surg 2012;47(6):1053-1057. doi: 10.1016/j.jpedsurg.2012.03.004.

  28. Bouchard S, Johnson MP, Flake AW, et al. The EXIT procedure: experience and outcome in 31 cases. J Pediatr Surg 2002;37(3):418-426.

  29. Hubbard AM, Crombleholme TM, Adzick NS. Prenatal MRI evaluation of giant neck masses in preparation for the fetal EXIT procedure. Am J Perinatol 1998; 15(4):253-257.

  30. Prontera W, Jaeggi ET, Pfizenmaier M, Tassaux D, Pfister RE. Ex utero intrapartum treatment (EXIT) of severe fetal hydrothorax. Arch Dis Child Fetal Neonatal Ed 2002;86(1):F58-60.




2020     |     www.medigraphic.com